The Hôpital Européen Georges-Pompidou is a French hospital located in Paris. The HEGP is under the aegis of the Assistance publique - Hôpitaux de Paris. Opened in 2001, the HEGP is the last-born Parisian hospital resulting from the merger of three older hospitals of the 15th district.

During the past decade, Georges Pompidou European University Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Georges Pompidou European University Hospital" are "Anemia, Sickle Cell" (1 trials), "Cardiac Surgery" (1 trials), "Cardiopulmonary Bypass" (1 trials), "Hemoglobin SC Disease" (1 trials) and "High Risk Bleeding" (1 trials). Many other conditions were trialed in "Georges Pompidou European University Hospital" in a lesser frequency.

Most popular intervention types in "Georges Pompidou European University Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "MP4CO" (1 trials), "Sodium chloride solution" (1 trials) and "standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Georges Pompidou European University Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Georges Pompidou European University Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Georges Pompidou European University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Georges Pompidou European University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".